chrisvoncsefalvay/vaers-outcomes huggingface dataset:
inadvertently received a full dose of the adult version of the Pfizer Covid vaccine; 6 years old boy, who inadvertently received a full dose of the adult version of the Pfizer Covid vaccine; loose stool; abdominal pain; This is a spontaneous report from a contactable consumer or other non-HCP (parent reporting for son) via Medical Information Team. A 6-year-old male patient received BNT162b2 (COMIRNATY, Solution for injection, Lot Number- UNKNOWN) via an unspecified route of administration on an unspecified date as dose number unknown single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Mother stated her son inadvertently received a full dose of the adult version of the Pfizer COVID-19 vaccine. She stated her child was complaining of loose stool, abdominal pain. She would like to know the side effects to look for specifically myocarditis and pericarditis. She would also like to know side effects of children who may have received a dose 3 times what is called for a child his age. The father and mother of the patient were very upset with lack of information provided to them, as they are very concerned that their child may develop, myocarditis, or pericarditis. Parents informed that, although the safety efficacy of the vaccine dose of 10ug, was comparable to those receiving the full dose of 30ug, there was no information with regards to side effects of a child smaller than 12 receiving a full dose, since the study conducted by Pfizer, provided a dose of 10ug and not 30ug. The reporter asked, what information do we have about the side effects the kids in the study had. The outcome of loose stool, abdominal pain was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow up.
Redness, swelling at site. Progressed to pain with fever of 103, inability to move limb.  Was given antibiotics at Urgent Care.
Fainting; Lost of taste; Dizziness; Vision changes double vision; Tingling and numbness in my face hands arms and legs; Tingling and numbness in my face hands arms and legs; Having a period every 10 days; Anemia; Ring in my ears; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3246), via an unspecified route of administration in the right arm on 29Jan2021 (at the age of 37-year-old), dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9265) administered via an unspecified route of administration in the left arm on 08Jan2021 (at the age of 37-year-old), dose 1, single for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. On 01Feb2021, the patient experienced fainting, lost of taste, dizziness, vision changes double vision, tingling and numbness in my face hands arms and legs, having a period every 10 days, anemia, ring in my ears. The patient underwent lab tests and procedures which included nasal swab COVID test: negative on an unspecified. The events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.
The vaccine was inadequately administered, too deep and too high, into the shoulder bursa. The patient developed sharp pain soon after which persisted for two days. Soon after she started with neurological symptoms including increased sweating in the affected arm, pain in the branchial plexus region, including arm and forearm, paresthesias in arm, forearm, and fingers, sensation of scapula being dislocated, and tightening sensation in the lateral aspect of the chest. Symptoms are worsening every day. There is a high suspicion that she is developing Parsonage-Turner syndrome.
This is a spontaneous report from a 26 year old female pt who in April 1999, received her 1st dose of Lymerix and subsequently, she experienced fatigue, joint pain and malaise. Outcome: the joint pain lessened, and the fatigue and malaise resolved. The pt received her 2nd dose on 5/21/99 and in July, 1999, she experienced pharyngitis, and joint pain. The joint pain has lessened but the pharyngitis persists. An ER or doctor visit was required. Lab work was done on 8/30/1999 and she was dx'd with Lyme disease. She was treated with doxycycline starting on 9/2/99. The pt reported that she had lack of effect from Lymerix (although she had not completed the Lymerix series). The most recent information, received on 9/14/99, reports the condition of the pt is ongoing.
Injection site soreness, severity of which varied throughout the day and is still sore after (expected). Headache approximately 14 hours after injection (expected). Took acetaminophen & ibuprofen w/ electrolyte beverage. Headache resolved; arm still sore.
Took 1st oral Typhoid capsule approximately 1030pm. The next afternoon became dizzy, nauseated, chills, felt fever later worsened to 103.2 called doctor approximately 11:00pm advised more Tylenol. One hour later temp still 103, but this fell asleep. 8/31 am - 100.  9/18/07 Received medical records from CDC which reveal patient experienced fever day after vaccines for travel.  Vax record included which confirm vax as reported.  Patient became dizzy, nauseated & had fever/chills following initial dose of oral typhoid.  Patient d/c vax then developed inflammation of lower eyelid.  Seen in ER where dx w/ocular herpes vx viral conjunctivitis.  Developed blurred vision & seen in ER by opthamologist who felt conjunctivitis.  Seen by private opthamologist out of state who dx w/herpes & PMD who felt viral.  Tx w/acyclovir.
Patient stated he developed a rash on his back near the waistline and down his right leg. Blisters that  itched and burned. one blister the size of a half dollar remains on his back , is brown in color and not totally round , more like a patch with varying depths of brown.  He took claritin to help with itch.  with his second vaccine today he became clammy,  and did not feel in his body, when asked his name he took a few moments to answer.  we advised he call a friend to take him home.
feels like her skin is on fire; fever (101.4 degrees Fahrenheit); This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feels like her skin is on fire) and PYREXIA (fever (101.4 degrees Fahrenheit)) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008XZ1A and 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced FEELING HOT (feels like her skin is on fire) and PYREXIA (fever (101.4 degrees Fahrenheit)). At the time of the report, FEELING HOT (feels like her skin is on fire) and PYREXIA (fever (101.4 degrees Fahrenheit)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4f (High) Body temperature-high.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. The patient took 2 tablets of Tylenol, to relieve the symptoms. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
After receiving Arexvy patient reported extreme pain in left arm, as well as redness and bruising. Patient says pain was so bad she could not lift her arm and had to call out of work the next day.
Covid-19 infection - tested positive 7/12, had fever, sinus congestion and pain, fatigue and it affected my lungs and caused my blood oxygen to fall to 89 on second night of illness. Was prescribed paxlovid which I took and finished course. The paxlovid cleared my lungs within a few hours which was amazing!
2AUG93 c/o of kidney pain, malaise, sweating, throat pain & chest compression; partner stated was pale; stated was in no mans land for 4 days, not well for 1 & 1/2 wks w/severe fatigue;
On 12/10/12, pt approached pharmacist to say she had developed cellulitis from her flu shot. Pt went to Dr. who gave her a steroid shot, XYZAL, PEPCID, and prednisone. The area cleared up with no additional adverse response.
Has some heat to it; hardness; swelling; itchy; A report was received from a consumer concerning a 37-year old, female patient who received Moderna's COVID-19 mRNA-1273 vaccine and experienced itchy (vaccination site pruritic), hardness (vaccination site induration), swelling (vaccination site swelling), has some heat to it (vaccination site warmth).   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 23 Dec 2020, approximately 2 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot #: unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On Dec 23 2020, a couple hours following vaccine administration in her right arm, the patient began to experience hardness, swelling, and reported it had some heat to it. She also experienced itch the following week. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, itchy, hardness, swelling, has some heat to it, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
UNCONTROBALLY SHAKES. trouble WALKING AND TALKING. Bad headache and heart racing  Fever 99.--Cold and sweating   Day After headache and fatigue
anxiety; exhaustion; teary; hands shaking; discombobulated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 16 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 16May2021 10:00 (Lot number: ew0183) at the age of 16 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01, lot number: ew0176,, administration route: intramuscular, vaccine location: left arm, time: 09:30), administration date: 26Apr2021, when the patient was 16 years old, for COVID-19 immunization. The following information was reported: ANXIETY (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "anxiety"; FATIGUE (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "exhaustion"; LACRIMATION INCREASED (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "teary"; TREMOR (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "hands shaking"; CONFUSIONAL STATE (non-serious) with onset 16May2021 22:00, outcome "recovered" (May2021), described as "discombobulated". Therapeutic measures were not taken as a result of anxiety, fatigue, lacrimation increased, tremor, confusional state.  No follow-up attempts are possible. No further information is expected.
There is no adverse reaction. This for is being filled out because patient is 4 months old and Flulaval (seasonal influenza) vaccine was given by mistake. Side effects and possible allergic reaction were discussed with vaccine nurse, and Mother was notified as well. Mom agreed to watch for redness/hot on vaccine site, swelling, and high fevers and to inform us right away if any of the symptoms shows up. As of today, 10/24/2019. No symptoms are recorded in patient's chart. No adverse reaction occurred.
I95.9 HYPOTENSION 1/18/2022 ANEMIA I95.9 HYPOTENSION 1/18/2022 NEUTROPENIC FEVER, UNSPECIFIED I95.9 HYPOTENSION 1/18/2022 ANEMIA I95.9 HYPOTENSION 1/18/2022 ATRIAL FIBRILLATION, PAROXYSMAL I95.9 HYPOTENSION 1/18/2022 DM 2 W CATARACT I95.9 HYPOTENSION 1/18/2022 PANCYTOPENIA I95.9 HYPOTENSION 1/18/2022 NEUTROPENIC FEVER, UNSPECIFIED I95.9 HYPOTENSION 1/18/2022 ANEMIA OF CHRONIC DISEASE I95.9 HYPOTENSION 1/18/2022 CKD STAGE 2 (GFR 60-89 W OTHER KIDNEY DAMAGE MARKER) I95.9 HYPOTENSION 1/18/2022 PALLIATIVE CARE
headache was heavy; her body and bones felt tired; sinuses felt heavy; shoulders are heavy; her thigh on the back is heavy; stated that she cannot move but can walk; neck on side when she has hiccups that she feels pain and in her back; neck on side when she has hiccups that she feels pain and in her back; This is a spontaneous report from a contactable consumer. A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 29Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On the second day (Jan2021), her body and bones felt tired when she stretched and her sinuses felt heavy. On 01Feb2021, her headache was heavy. She took Benadryl. Her shoulders, neck on side and her thigh on the back were heavy on 2021. She cannot move but can walk on 2021. When she walks that it feels likes electricity. Also on 2021, her neck on side when she has hiccups that she feels pain and in her back. Patient was worried about it and wanted to know if it was normal to feel like this after the vaccine. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Patient  has frequent nose bleeds since having the vaccine. . He has not had profuse bleeding or an amount that causes drips but when he blows his nose there is blood that comes out with mucus. It doesn?t happen every time but he has noticed this since receiving the vaccine.
Half hour after injection my throat felt tight and my OPPOSITE arm hurt.  About 1:00 am I got so chilled I couldn't get warm, I did not take my temperature because my thermometer goes under my tongue and I was afraid I would break it cause my teeth were chattering so bad. The next day I felt very weak and nauseous.  Then I discovered I had a rash at the top of my legs. My left breast was very sore I felt like  someone punched me. Today is Monday and I still have diarrhea.
Had a little bit of arm irritation; Bivalent booster dose that leaked onto his arm during administration; Not sure how much of the vaccine he has received; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE IRRITATION (Had a little bit of arm irritation), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Bivalent booster dose that leaked onto his arm during administration) and UNDERDOSE (Not sure how much of the vaccine he has received) in a 67-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No medical history was provided by the reporter.  Concomitant products included INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.    On 29-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Sep-2022, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Bivalent booster dose that leaked onto his arm during administration) and UNDERDOSE (Not sure how much of the vaccine he has received). On an unknown date, the patient experienced VACCINATION SITE IRRITATION (Had a little bit of arm irritation). At the time of the report, VACCINATION SITE IRRITATION (Had a little bit of arm irritation), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Bivalent booster dose that leaked onto his arm during administration) and UNDERDOSE (Not sure how much of the vaccine he has received) outcome was unknown.            On 10-Feb-2021, patient received first dose of Moderna COVID-19 vaccine (lot number 025420A, Intramuscular) On 10-Mar-2021, patient received second dose of Moderna COVID-19 vaccine (lot number 002A2PA) On 4-Nov-2021, patient received booster dose of Moderna COVID-19 vaccine (lot number 076C21A) The most recent dose was a bivalent booster dose that leaked onto patient's arm during administration. Patient was not sure how much of the vaccine patient has received. Patient has had a little bit of arm irritation after receiving those injections, and took the flu shot the same time as the most recent dose.  No additional doses, medications, or treatments have been administered up to that point.
Hives on stomach and chest 48 hours after; This is a spontaneous report from a contactable other healthcare professional. A 55-year-old female patient received the first dose of bnt162b2 (lot no. and expiry date unknown), intramuscular in left arm on 02Jan2021 16:15 at single dose for Covid-19 immunization. Medical history included mastocytosis. The patient is not pregnant. The patient's concomitant medications were not reported. The most recent COVID-19 vaccine was administered in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 04Jan2021 at 16:00, the patient experienced hives on stomach and chest 48 hours after. No treatment was received for the event. The outcome of the event was recovering. The event was assessed as non-serious.  Information on the lot/batch number has been requested.
Moderna COVID-19 Vaccine EUA. High fever, chills, hot flashes, headache, sensitivity to light, extreme fatigue, nausea, and vomiting. Symptoms began to diminish ~24 hours after they began; after 72 hours almost all symptoms were gone except for fatigue which lasted a few more days.
Information has been received from a pharmacist, concerning a patient (age and gender not specified), who was vaccinated on an unspecified date ("in the past"), with a dose of PNEMOVAX 23, and subsequently had an allergic reaction (symptoms and details unspecified) to the vaccine.  At the time of this report, it was unknown if the patient had recovered from the event.  Additional information has been requested.
swelling; redness; This non-serious case was reported by a nurse via sales rep and described the occurrence of swelling in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced swelling (Verbatim: swelling) and erythema (Verbatim: redness). The outcome of the swelling and erythema were not reported.   It was unknown if the reporter considered the swelling and erythema to be related to Arexvy.     It was unknown if the company considered the swelling and erythema to be related to Arexvy.   Additional Information: GSK Receipt Date: 18-SEP-2023 The nurse practitioner stated after getting the Arexvy vaccine patient experienced swelling and redness. The reporter did not consented to followup.
11 AM pt reported feeling throat tightness, increased dry cough, raspy voice. Pt states she took Mestinon tablet. Administered Benadryl 25mg PO per adult Influenza vaccine (1105). Dr notified and examined pt. BP 122/76 P 72/min, oxygen sat RA 99%. 1107 Am administered Epinephrine (1:1000) 0.3cc SQ in R arm. Pt alert denies SOB. At 11:20 am pt reports feeling much better, no throat tightness. Pt discharged with Rx for Prednisone taper and instruction.
Initial report was received 18 September 2008 from a health care professional.  A 12-year-old female patient had received a left deltoid intramuscular injection of MENACTRA, lot number U2636AA and a first dose right deltoid intramuscular injection of GARDASIL, lot number 0843X (manufacturer Merck) on 11 September 2008, and on the evening of vaccination, she developed numbness in her face.  By the following morning, the numbness had worsened and she complained of a prickly feeling in her cheeks and around her lips, and her face felt hot and cold.  The patient's face also appeared pink and puffy.  By the afternoon, her lips became tingly.  The patient's mother called their health care provided to report the symptoms and stated the patient complained that her head was hurting (onset time and date not reported).  The patient had not experienced any fever and no other symptoms occurred.  The patient received corrective treatment with BENADRYL.  By the following morning (date not reported), all symptoms had resolved.  The patient had also received an injection of ADACEL (lot number not reported) within four weeks prior to receipt of MENACTRA and GARDASIL.  No further information was provided.
Diarhhea,bleeding gums-one day, sore throat, some loss of energy. USED gargling and lozengers for sore throat and more rest for the loss of energy.Drank plenty of fluids and let the diarrhea run its coarse.
Seizure; received a third dose; This case was reported by a consumer via call center representative and described the occurrence of seizure in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received both doses in 2019, but did not recall the exact date on pharmacy).   On 3rd March 2020, the patient received the 3rd dose of Shingrix (intramuscular). On 3rd March 2020, unknown after receiving Shingrix, the patient experienced extra dose administered. In April 2020, the patient experienced seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the seizure and extra dose administered were unknown.   It was unknown if the reporter considered the seizure to be related to Shingrix.  Additional details were provide as follows: This case was reported by the patient's wife. The patient received 3rd dose of Shingrix on left upper deltoid at the clinic, which led to extra dose administered. A month after vaccination, the patient experienced seizure and was wondering if the cause of the seizure is related to receiving the third dose. The patient referred to their healthcare professional. The reporter consented to follow up.
Patient Received Varivax #2 right upper arm 03/28/07. Rash developed at injection site 03/31/07 and patches of vesicles spread to the entire right arm. Classic herpes zoster.
After receiving 1st dosage on 2/24/21   me as wife got 2X  facial rash  . 1st time very red looking like a racoon facial rash. 2nd time less strong.  I began to suspect her had gotten the vaccine and NEVER TOLD ME.  I had begged not to before as  I  9 +(+HIM) ARE TOTALLY IMMUNO COMPROMISED after 2nd dosage ON 3/17/20121  he developed a rash  trunk /back ( which I took picture day after very red skin). he also developed his right foot totally  BRUISED AND LOTS OF SWELLIN OF LOWER LEG
3pm leg started to swell to toes. taken to ER 9pm for edema to leg and toes and no fever. No redness; tender to touch (9/2/04 per Dr left leg swelling status post vaccine).